Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Completed × Ependymoma × Clear all

Phase

Phase 1 41 Phase 2 33 Phase NA 6 Phase EARLY_PHASE1 5 Phase 1/2 5 Phase 3 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 33 Breast Neoplasms 32 Prostatic Neoplasms 27 Leukemia, Myeloid, Acute 21 Carcinoma, Non-Small-Cell Lung 19 Colorectal Neoplasms 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Neoplasm Metastasis 14 Polycystic Ovary Syndrome 11 Multiple Myeloma 11 Lung Neoplasms 11 Carcinoma, Hepatocellular 11 Stomach Neoplasms 10 Urinary Bladder Neoplasms 8 Pancreatic Neoplasms 8 Motor Activity 8 Lymphoma 8 Recurrence 7 Myelodysplastic Syndromes 7 Liver Neoplasms 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia 7 Head and Neck Neoplasms 7 Esophageal Neoplasms 7 Brain Neoplasms 7 Pain 6 Ovarian Neoplasms 6 Lymphoma, Non-Hodgkin 6 Lymphoma, Follicular 6 Hematologic Neoplasms 6

Interventions

trofosfamide 1 Thiotepa 1 Temozolomide 1 Etoposide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00749723 2018-07-20

HIT-REZ-2005

University Hospital, Bonn

Phase 2/3 Completed

Brain Neoplasms, Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡